Correlation Between Codexis and Orchestra BioMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Codexis and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codexis and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Codexis and Orchestra BioMed Holdings, you can compare the effects of market volatilities on Codexis and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codexis with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codexis and Orchestra BioMed.

Diversification Opportunities for Codexis and Orchestra BioMed

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Codexis and Orchestra is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Codexis and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and Codexis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codexis are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of Codexis i.e., Codexis and Orchestra BioMed go up and down completely randomly.

Pair Corralation between Codexis and Orchestra BioMed

Given the investment horizon of 90 days Codexis is expected to under-perform the Orchestra BioMed. But the stock apears to be less risky and, when comparing its historical volatility, Codexis is 1.63 times less risky than Orchestra BioMed. The stock trades about -0.07 of its potential returns per unit of risk. The Orchestra BioMed Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  329.00  in Orchestra BioMed Holdings on July 25, 2025 and sell it today you would earn a total of  27.00  from holding Orchestra BioMed Holdings or generate 8.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Codexis  vs.  Orchestra BioMed Holdings

 Performance 
       Timeline  
Codexis 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Codexis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in November 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Orchestra BioMed Holdings 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Orchestra BioMed Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Orchestra BioMed displayed solid returns over the last few months and may actually be approaching a breakup point.

Codexis and Orchestra BioMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Codexis and Orchestra BioMed

The main advantage of trading using opposite Codexis and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codexis position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.
The idea behind Codexis and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges